BIOPURE
competitor's raw materials supplies. Technological advances in blood storage may decrease demand.
Increasing demand from aging population DEMOGRAPHICS, page 650 Undetermined approval date by FDA, LEGAL
Northfield doesn't have a facility. COMPETITIVE. Baxter is strongest player. COMPETITIVE
Baxter's R&D budget is dependent upon stock price. VARYING R&D BUDGETS
Baxter has more net losses to recoup.
Offer growth capability for investors. FINANCIAL MARKETS Some segments of population may oppose and refuse the use of animal (cow) products. DEMOGRAPHICS
Seasonal cycles of shortage in blood supplies increases demand for this product. Negative public reaction if we decide to withhold blood substitue for animals for reasons of profit. SOCIAL
Competitior products require refrigeration. TRANSPORTATION Mad cow disease. NATURAL
Competitor products have shorter shelf-lifes. COMPETITION
Perpetual market demand.
5 journals to choose
6 Trade shows a year-valued source of info
Immediate revenue generation for Oxiglobin